跳至主要内容
临床试验/NCT04534309
NCT04534309已完成不适用

Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2 个研究点 分布在 1 个国家目标入组 340 人开始时间: 2020年9月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
340
试验地点
2
主要终点
Weight change at 6 months in Coach-Directed Program

研究概览

简要总结

Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project

详细描述

The objective of the ASPIRE Project is to design, implement, and evaluate a real-world, lifestyle-based, support for overweight or obese cancer survivors in both urban and rural areas of Maryland. The project will provide three options of support to encourage lifestyle change to achieve and maintain a healthy weight for cancer survivors:

  1. Self-Directed Weight Loss: educational materials only;
  2. App-Directed Weight Loss: educational materials, weight loss app with weekly e-mail support; and
  3. Coach-Directed Weight Loss: educational materials, weight loss app, weekly e-mail support and one-to-one weekly telephonic coach support.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • previously diagnosed with a malignant solid tumor,
  • completed all required surgical, and/or chemotherapy and/or radiation curative intent therapy at least three months prior to enrollment,
  • anticipated treatment-free life span of 12 months or longer.
  • chemoprophylaxis with tamoxifen or aromatase inhibitors for breast cancer in women will be permitted
  • anti- Luteinizing-hormone releasing therapy for prostate cancer in men will be permitted.
  • BMI ≥ 25 kg/m2 (BMI ≥ 23 kg/m2 for Asians) and weight ≤ 400 lbs.
  • have an email address for regular personal use
  • Additional criteria for participants in weight tracking (self-directed or app directed)
  • willingness to record/transmit quarterly weights for 12 months
  • Additional criteria for App-Directed Program:
  • willingness to change diet and increase physical activity and track weight, diet and physical activity
  • have a smart phone for personal use
  • sufficient data plan/Internet to support daily use of weight loss app*
  • Additional Criteria for Coach-Directed Weight Loss Program
  • willingness to lose weight by changing diet and physical activity habits
  • willingness to track weight, diet and physical activity
  • willingness to record/transmit quarterly weights for 12 months
  • smart phone for personal use
  • data plan/Internet to support daily use of weight loss app*
  • willingness to complete coaching calls (12 weekly calls and 3 monthly calls)
  • sufficient call plan to support coaching calls
  • a corresponding website could be used, then daily Internet access is required for person use.

排除标准

  • received any chemotherapy (unless anti-hormonal therapy) and/or radiation three months or less prior to the proposed program date
  • women who are breastfeeding, pregnant, or planning pregnancy within the next year
  • Additional exclusion criteria for participants in weight tracking and/or Coach-Directed Program
  • self-identification of uncontrolled concurrent medical condition likely to limit compliance with the program as determined by investigators.
  • current involvement in another organized weight loss program
  • current use of steroids or other medication known to affect body weight
  • bariatric surgery scheduled within the next 6 months, or
  • plan to move outside the continental US in the next 12 months

结局指标

主要结局

Weight change at 6 months in Coach-Directed Program

时间窗: Baseline and 6 months

Evaluate the "effectiveness" of the Coach-Directed weight loss programs in a real world setting by examining weight change \[in kilograms (kg)\] at 6-months.

次要结局

  • Weight change at 6 months in Self-Directed and App-Directed Weight Loss Programs(Baseline and 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Behavioral Weight Loss Program for Cancer Survivors... | 临床试验